Latest Advances in Lung Cancer Research

A new UK study found lung cancer survivors living in high-pollution areas had over 6 times the risk of a second, separate lung cancer.

Severe viral infections, such as COVID-19, can increase the risk of lung cancer through immune cell changes, though vaccination significantly reduces these long-term harmful effects.

A new JAMA review shows that small cell lung cancer, which affects 95% smokers and has only 12-30% five-year survival, is seeing breakthrough improvements with immunotherapy extending survival to 56 months for early-stage disease, though advanced cases remain challenging with most patients relapsing within three months.

The study highlights that the timing of irAEs depends on the specific immunotherapy and recent treatment history.

New research separates the effects of smoking, environment, genetics, and healthcare access on lung cancer mortality, providing insights for better prevention strategies.

Increasing lung cancer cases in non-smokers highlight the need for research into causes and improved detection methods

New study reveals higher lung cancer incidence in women under 65 than in men, with rates increasing among younger women despite declining smoking trends.

New study reveals genetic factors protect some lifelong smokers from lung cancer, identifying robust mechanisms that limit mutation accumulation and improve early detection strategies

Wildfire smoke exposure increases lung cancer risk and worsens patient outcomes, particularly for vulnerable populations and those recovering from lung cancer surgery.

A University of Illinois Chicago study finds a correlation between living in violent neighborhoods and an increased risk of cancer.

Non-smoking Asian American and Pacific Islander women face higher lung cancer risks, prompting research into genetic and environmental causes and new treatments.